FDA guidance
Calcium DTPA and Zinc DTPA Drug Products-Submitting a New Drug Application
FDA guidance · Final · issued Aug 13, 2004
Key facts
| Title | Calcium DTPA and Zinc DTPA Drug Products-Submitting a New Drug Application |
|---|---|
| Status | Final |
| Issue date | Aug 13, 2004 |
| Center | Center for Drug Evaluation and Research |
| Issuing office | Center for Drug Evaluation and Research |
| Communication type | Guidance Document |
| Regulated product | Drugs |
| Docket number | None found |
| Open for comment | No |
| Document on fda.gov | fda.gov |
At a glance
- None Product codes referenced
- None Recognized standards referenced
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA guidance documents
FDA guidance documents describe the agency's current thinking on regulatory topics. Drafts are issued for comment before a final version is published.
Source: U.S. Food and Drug Administration (FDA), Guidance Documents